Abstract
We would like to respond to the comments made by Pu Song and Xingshun Xu about the chosen administration of IV immunoglobulin (IVIG), which is based on a regimen for chronic inflammatory demyelinating polyneuropathy (CIPD). These authors also expressed doubts about our conclusion that IVIG was not effective in patients with painful with idiopathic small fiber neuropathy (I-SFN).
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call